| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.485 | 14.581 | 7.407 | 13.651 | 10.768 | 18.300 | 26.271 | 23.134 | 20.149 |
| Total Income - EUR | - | 6.485 | 14.582 | 7.407 | 13.651 | 10.769 | 18.300 | 26.271 | 23.134 | 20.149 |
| Total Expenses - EUR | - | 3.837 | 8.975 | 7.912 | 9.288 | 5.880 | 7.581 | 10.139 | 16.856 | 16.233 |
| Gross Profit/Loss - EUR | - | 2.648 | 5.607 | -505 | 4.363 | 4.889 | 10.719 | 16.132 | 6.279 | 3.917 |
| Net Profit/Loss - EUR | - | 2.454 | 5.170 | -727 | 3.954 | 4.589 | 10.181 | 15.452 | 6.056 | 3.324 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sma Medconsult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 591 | 438 | 287 |
| Current Assets | - | 6.373 | 14.164 | 11.107 | 10.758 | 7.990 | 12.422 | 35.523 | 7.893 | 7.072 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 211 | 0 | 303 | 13.767 | 2.109 | 737 |
| Cash | - | 6.373 | 14.164 | 11.107 | 10.547 | 7.990 | 12.119 | 21.756 | 5.784 | 6.335 |
| Shareholders Funds | - | 2.498 | 5.222 | -676 | 3.291 | 7.818 | 10.229 | 15.501 | 6.289 | 3.372 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.875 | 8.942 | 11.783 | 7.467 | 172 | 2.193 | 20.613 | 2.043 | 3.986 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sma Medconsult Srl